Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

27/06/2017 ​Barcelona Synchrotron Park’s sustainable brownfield restoration program presented at AquaConSoil 2017 21/06/2017 Catalonia confirms itself as pole of attraction for foreign investments 15/06/2017 Construction of the Natura Bissé’s new world headquarters is well on its way 06/06/2017 ​Walk in the Park: the biodiversity routes await you 31/05/2017 UAB second most innovative university in Spain 24/05/2017 PRUAB: 10 years in strengthening relationships between research and business fabric
16 17 18 19 20 21 22 23 24 25 26